TGA
Ozempic shortages to continue: Butler
Novo Nordisk “simply doesn’t have the factories” to meet growing demand for Ozempic, Health Minister says Shortages of Novo Nordisk’s diabetes medication, Ozempic (semaglutide) are likely to continue into 2025, …
Zactin Tabs ‘shortage resolved’
TGA announces supply of Zactin Tabs “has returned to normal” Alphapharm notified the Therapeutic Goods Administration (TGA) that the shortage of Zactin Tabs (fluoxetine 20mg dispersible tablets) “has resolved”. The …
Publisher cops TGA’s ire
Regulator issues infringement notices over an article that allegedly “promoted the use or supply of medicinal cannabis” Publisher, News Life Media Pty Ltd, is facing three infringement notices totalling $56,340 …
Warning issued over widely used medicinal herb
A herb used in around 100 listed medicines is linked to allergic reactions, including anaphylaxis, with reports increasing since 2019, the TGA says Medicines containing the herb Andrographis paniculata (andrographis) may …
Compound issues
Warning issued over compounded wind and colic products The Therapeutic Goods Administration (TGA) has issued a warning that it has received reports of serious side effects in infants given compounded …
Oral opioid shortages to continue
Shortages of Oxynorm capsules and Ordine oral liquid are expected to last until late 2024, the TGA reports Manufacturers of two oral opioid products are forecasting that shortages of some …
Profession needs vape guidelines
TGA urged to review vapes and produce guidelines to allay pharmacists’ concerns about stocking products The Therapeutic Goods Administration (TGA) needs to review the safety, efficacy and performance of vaping …
New criminal offences and civil penalties on vapes: TGA
The TGA has issued a statement about the changes to vaping which will take effect on from July 2024 “The new legislation introduces a single, consistent framework that applies nationally …
TGA takes RAT action
Federal Court proceedings have been initiated over the alleged importation and supply of unapproved Covid-19 RATs Queensland-based company, Key Promotional Products Pty Ltd (KPP) and the husband of the firm’s …
Vyvanse shortages return
Less than two months after the TGA declared shortages of Vyvanse to be “resolved” the regulator is now reporting the medication is once again in short supply The Therapeutic Goods …
Suspended sentence for Therapeutic Goods Act breaches
Business owner handed a two-year suspended sentence for his role in the unlawful manufacture, supply and export of performance and image-enhancing drugs Businessman, Ryan Gregory McTeigue, has avoided time behind …
Zactin Tabs shortage set to continue
TGA extends fluoxetine substitution instrument in response to ongoing manufacturing issues Supply shortages impacting Zactin Tabs (fluoxetine 20mg dispersible tablets) are expected to continue until 30 June 2024, the medication’s …